News
TipRanks on MSN3h
AstraZeneca’s DESTINY-Endometrial01: A New Frontier in Endometrial Cancer Treatment
AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The DESTINY-Endometrial01 study aims to evaluate the ...
TipRanks on MSN3h
Gilead Sciences Advances in NSCLC Treatment: Key Study Update
Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences, in collaboration with Merck Sharp & Dohme LLC, is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback